<DOC>
	<DOCNO>NCT02879942</DOCNO>
	<brief_summary>Preeclampsia ( PE ) intrauterine growth restriction ( IUGR ) clinical manifestation placental insufficiency . These complication affect 5-15 % pregnancy , responsible 20 % preterm birth . Women develop PE pregnancy also increase risk cardiovascular event , short long term . This justifies need improve diagnostic tool identify patient risk complication . PE IUGR multifactorial entity . Screening algorithms thus include several parameter achieve high detection rate . Research mainly focus analysis biophysical biochemical parameter , study placenta include current diagnostic strategy . Investigators hypothesize detection rate preeclampsia intrauterine growth restriction could improve study placental characteristic first trim pregnancy .</brief_summary>
	<brief_title>First Trimester Placental Assessment Screening Preeclampsia Intrauterine Growth Restriction</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Angiogenesis Inhibitors</mesh_term>
	<mesh_term>Angiogenesis Inducing Agents</mesh_term>
	<criteria>pregnancy fetuses CRL 45 80mm absence chromosomal abnormality absence congenital anomaly absence congenital infection patient accept participate study multiple pregnancy pregnancy without ultrasonographic confirmation gestational age</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Placental volume</keyword>
	<keyword>First-trimester screening</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>Preeclampsia</keyword>
	<keyword>Intrauterine growth restriction</keyword>
	<keyword>Biochemical marker</keyword>
	<keyword>Uterine artery doppler</keyword>
</DOC>